Skip to main content
Log in

Measurement of activated clotting time and whole blood heparin concentration during cardiopulmonary bypass

  • Letter to the editor
  • Published:
The Japanese Journal of Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Komiya T, Ban K, Yamazaki K, Ishii O, Nakamura T, Kanzaki Y. The significance of heparin concentration measurement during cardiopulmonary bypass. Effect of heparin-coated circuit during normothermic bypass. J Jpn Assn Thorac Surg 1997; 45: 1810–5.

    CAS  Google Scholar 

  2. Watanabe T, Yasuura K, Maseki T, Oohara Y, Itoh T, Yuasa T, Nishizawa T, Kawaratani Y, Murase M. Activated clotting time and whole blood heparin concentration during cardiopulmonary bypass. Jpn J Artif Organs 1997; 26: 349–53.

    Google Scholar 

  3. Tabuchi N, de Haan J, Boostran PW, van Oeveren W. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 823–33.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Watanabe, T., Shirota, K. Measurement of activated clotting time and whole blood heparin concentration during cardiopulmonary bypass. Jpn J Thorac Caridovasc Surg 46, 530 (1998). https://doi.org/10.1007/BF03250593

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03250593

Keywords

Navigation